You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS-blockers

Showing 1 - 25 of 1,219
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Use of CCB and Breast Cancer Risk

Active, not recruiting
  • Hypertension,Essential
  • Breast Cancer
  • Calcium channel blocker
  • +5 more
  • Bentley, Western Australia, Australia
    Curtin university
Aug 1, 2023

History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection Trial in Paris (1: discontinuation of

Terminated
  • History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection
  • 1: discontinuation of RAS blocker therapy
  • 2: continuation of RAS blocker therapy
  • Paris, France
    Cardiologie, Groupe Hospitalier Pitié-Salpêtrière
Apr 8, 2021

Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

Completed
Has Results
  • Hypertension
  • COVID-19
  • Angiotensin converting enzyme inhibitor
  • +2 more
  • Kiev, Please Select, Ukraine
    Medical Practice Prof D.Ivanov
Feb 16, 2022

Diabetes, Type 2, Diabetic Kidney Disease Trial in Amsterdam (Empagliflozin 10 MG, Losartan 50Mg Tab, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Diabetic Kidney Disease
  • Empagliflozin 10 MG
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Oct 5, 2021

Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

Not yet recruiting
  • Diabetic Nephropathy Type 2
  • Empagliflozin 25 MG
  • Enalapril Maleate 20 mg
  • (no location specified)
May 9, 2022

Hypertensive Emergency-associated Hemolytic Uremic Syndrome Trial in Paris (Soliris®, Renin angiotensin system blockers)

Not yet recruiting
  • Hypertensive Emergency-associated Hemolytic Uremic Syndrome
  • Paris, France
    Tenon Hospital
Feb 3, 2023

The Effect of RAAS Blockers on ACE2 Levels

Completed
  • Renin-Angiotensin System
  • ACE inhibitor ,angiotensin receptor blockers
  • Cairo, Select A State Or Province, Egypt
    Ainshams University
Jun 10, 2022

Renal Insufficiency, Chronic, Proteinuria Trial in Madrid (Lisinopril, Amlodipine)

Recruiting
  • Renal Insufficiency, Chronic
  • Proteinuria
  • Madrid, Spain
    Gregorio Maranon Hospital
Feb 21, 2019

SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)

Completed
Has Results
  • SARS-CoV-2
  • COVID-19
  • ACE inhibitor, angiotensin receptor blocker
  • Innsbruck, Tyrol, Austria
  • +30 more
Aug 18, 2022

Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

Recruiting
  • Diabetes Mellitus
  • Cardiovascular Diseases
  • Renin-angiotensin-aldosterone system inhibitors
  • +2 more
  • Singapore, Singapore
    Singapore General Hospital (SGH)
Apr 28, 2021

Angiotensin Converting Enzyme Inhibitors and Angiotensin

Not yet recruiting
  • COVID-19 Pneumonia
  • Covid_19
  • (no location specified)
Jun 5, 2022

Safety Issues, Chronic Kidney Diseases Trial in Baltimore (Sick-Day Protocol, Usual Care)

Completed
Has Results
  • Safety Issues
  • Chronic Kidney Diseases
  • Sick-Day Protocol
  • Usual Care
  • Baltimore, Maryland
    Baltimore VA Medical Center
Apr 12, 2021

Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

Not yet recruiting
  • Aortic Valve Stenosis
  • Angiotensin Receptor-Neprilysin Inhibitor
  • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 4, 2023

Kidney Transplant; Complications Trial in Chapel Hill (Finerenone Oral Tablet, Placebo)

Not yet recruiting
  • Kidney Transplant; Complications
  • Finerenone Oral Tablet
  • Placebo
  • Chapel Hill, North Carolina
    UNC Eastowne Kidney Transplant Clinic
Sep 28, 2023

Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)

Recruiting
  • Angiotensin/Renin/Aldosterone Hypertension
  • +2 more
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Aug 16, 2022

COVID Trial in London (TRV027, sodium chloride 0.9%)

Completed
  • COVID
  • TRV027
  • sodium chloride 0.9%
  • London, United Kingdom
    Imperial College NHS Trust
May 25, 2021

Stroke, Old Age Trial in Boston (Subject-specific optimized RAS, Active walking)

Recruiting
  • Stroke
  • Old Age
  • Subject-specific optimized RAS
  • Active walking
  • Boston, Massachusetts
    Boston University Neuromotor Recovery Laboratory
Oct 13, 2023

Covid-19 Trial in Hellerup, Herlev (Discontinuation of ACEi/ARB, Continuation of ACEi/ARB)

Completed
  • Covid-19
  • Discontinuation of ACEi/ARB
  • Continuation of ACEi/ARB
  • Hellerup, Capital Region Of Denmark, Denmark
  • +1 more
Jan 17, 2023

Renin Angiotensin System, Surgery Trial in Paris (continuation of the RAS-inhibitors, discontinuation of the RAS-inhibitors)

Recruiting
  • Renin Angiotensin System
  • Surgery
  • continuation of the RAS-inhibitors
  • discontinuation of the RAS-inhibitors
  • Paris, France
    Hospital Lariboisiere
Mar 21, 2022

COVID-19 Trial in Austria (Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care)

Unknown status
  • COVID-19
  • Chloroquine or Hydroxychloroquine
  • +11 more
  • Innsbruck, Tirol, Austria
  • +8 more
Feb 25, 2021

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Acoustic Stimulation, Parkinson Disease, Electroencephalography Trial (Upper-limb training involving RAS, Upper-limb training

Not yet recruiting
  • Acoustic Stimulation
  • +2 more
  • Upper-limb training involving RAS
  • Upper-limb training without the aid of RAS
  • (no location specified)
Mar 13, 2023

Parkinson Disease Trial (Rhythmic Auditory Stimulation (RAS))

Not yet recruiting
  • Parkinson Disease
  • Rhythmic Auditory Stimulation (RAS)
  • (no location specified)
Mar 9, 2023

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022